Litigation Watch: ARTHRITIS DRUGS is a monthly newsletter for attorneys, focusing on drugs used to treat osteo and rheumatoid arthritis: Arava, Enbrel, Remicade, Humira, Vioxx, Celebrex and more. These drugs are already the subject of litigation following claims that they cause everything from liver damage to cancer, heart failure and strokes. Each issue features case news, interviews, legislative and FDA updates, and reviews from current medical literature.
Arthritis Drugs - Issue: 25
Analysis Finds Traditional NSAIDs Carry Similar Heart Risks to Cox-2s
Hearing on Merck's Motion to Set Aside Ernst Verdict Delayed
Parties Agree to Postpone First Celebrex Trial
Defendants Seek to Dismiss Purchaser Plaintiffs' Bextra, Celebrex Claims
Court Reverses Ruling, Allows Failure-to-Warn Claim against Distributors
Calif. Plaintiff Says Merck's Affirmative Defenses Have No Merit
New APPROVe Data Suggest Vioxx Risk in Short-Term Use
Judge Says Merck Shareholders Failed to Adequately Plead Demand Futility
